Apellis' drug better than Soliris in improving hemoglobin levels in trial

Apellis Pharmaceuticals Inc said on Tuesday its experimental drug for a blood disorder showed greater improvement in patients' hemoglobin levels than market leader Alexion Pharmaceuticals Inc's Soliris.